Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Relative Bioavailability of an ESK-001 Tablet Versus Liquid Formulation, and the Effect of Food or Gastric Acid Reduction on the Pharmacokinetics of ESK-001 in Healthy Participants

Next Previous
X
Search
Trial Profile

The Relative Bioavailability of an ESK-001 Tablet Versus Liquid Formulation, and the Effect of Food or Gastric Acid Reduction on the Pharmacokinetics of ESK-001 in Healthy Participants

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 06 May 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ESK-001 (Primary) ; Rabeprazole
  • Indications Autoimmune disorders; Psoriasis; Systemic lupus erythematosus; Uveitis
  • Focus Pharmacokinetics
  • Sponsors Alumis

    • Most Recent Events

    • 12 Mar 2024 Results from ESK001-002 and ESK001-003, presented at the American Academy of Dermatology annual Meeting 2024
    • 04 Mar 2024 According to Alumis media release, the company will highlight pharmacokinetic and pharmacodynamic data of healthy participants from this study during e-poster presentation at the American Academy of Dermatology Annual Meeting taking place March 8-12, 2024, in San Diego, CA.
    • 06 May 2023 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top